#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nodal marginal zone B-cell lymphoma Spinal cord injury cervical Central nervous system neoplasm Neonatal asphyxia Gastrointestinal disorder Erdheim-Chester disease Metastases to central nervous system Fibrous dysplasia of bone Hairy cell leukaemia Squamous cell carcinoma of the oral cavity Vaginal cancer Hereditary hypophosphataemic rickets Behcet's syndrome Acute lymphocytic leukaemia recurrent Thalassaemia More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Basic Information SAPHO syndrome – Diagnostics Mucopolysaccharidosis I Tuberous sclerosis complex Crigler-Najjar syndrome – Treatment Progressive supranuclear palsy – Treatment Vascular malformation – Treatment Hepatoblastoma – Diagnostics Mitochondrial myopathy – Basic Information Pleural mesothelioma malignant – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abelacimab Tildrakizumab Lepidoglyphus Destructor IM-101 Dorocubicel Tradipitant Mbf-015 GSK5764227 Acoramidis Hydrochloride Nicotine Resinate Ciprofloxacin Hydrochloride Pirfenidone Danicopan Metoprolol Succinate Calcium Oxybate TALADEGIB Birtamimab Vortioxetine Hydrobromide ANERATRIGINE MESILATE Brentuximab Vedotin More therapies…

    Learn about Your Condition

    Follicular thyroid cancer MELAS syndrome Metabolic syndrome Venous thrombosis limb Hyperglycaemia Aortic valve disease Childhood asthma Urinary incontinence Thyroid cancer metastatic Erythema Agitation postoperative Sleep disorder Pain in extremity Anaemia Nodal osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on Reducing or Stopping Immunosuppression with Tacrolimus and Ciclosporin in Patients with Late Kidney Transplant Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus
    Spain

  • Study on Reducing Tacrolimus in Kidney Transplant Patients with Low Immunological Risk Using Tacrolimus, Mycophenolic Acid, and Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Iohexol
    • Prednisolone Metasulfobenzoate Sodium
    • Mycophenolic Acid
    France Norway Spain

  • Study on Switching from Tacrolimus or Ciclosporin to Belatacept for Adolescents with Kidney Transplants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Ciclosporin
    • Tacrolimus
    Belgium France Germany Italy The Netherlands Spain

  • Study on Preventing Rejection in Kidney Transplant Patients Using Rabbit Anti-Human Thymocyte Immunoglobulin and Basiliximab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on the Safety and Effectiveness of Oral Semaglutide for Patients with High Blood Sugar After Kidney Transplantation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hyperglycaemia
    • Renal transplant
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Study on Organ Preservation in Kidney, Liver, and Pancreas Transplants Using Custodiol-N Solution Compared to a Drug Combination for Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Renal transplant
    Investigated Drugs:
    • Aspartic Acid
    • Calcium
    • Chloride Ion
    Austria
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!